Related Experiment Video
Updated: May 7, 2026

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice
Published on: August 2, 2018
Deletion of DWORF does not affect cardiac function in aging and in PLN-R14del cardiomyopathy
Nienke M Stege1, Vivian Oliveira Nunes Teixeira1, Sietske N Zijlstra1
1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Insights
Deleting the dwarf open reading frame (DWORF) gene does not worsen cardiomyopathy caused by the phospholamban (PLN) R14del variant in mice. DWORF is not essential for normal heart function during aging.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Genetic Models of Heart Disease
Background:
- The phospholamban (PLN) p.Arg14del variant causes cardiomyopathy and heart failure (HF).
- Dwarf open reading frame (DWORF) counteracts PLN in the sarcoplasmic reticulum and can delay disease in PLN-R14del mice.
- The effect of DWORF absence on PLN-R14del cardiomyopathy progression was unknown.
Purpose of the Study:
- To investigate if deleting DWORF accelerates age-dependent cardiomyopathy in wild-type (WT) and PLN-R14del mice.
- To determine if DWORF is essential for cardiac function during aging.
Main Methods:
- Generation and aging of DWORF-deleted (DWORF-/-) mice and PLN-R14del (R14-/-) mice, some with combined DWORF and R14 deletions.
- Assessment of cardiac function, including left ventricular ejection fraction (LVEF), over time.
- Analysis of gene expression markers for cardiac remodeling and fibrosis, and histological evaluation of cardiac fibrosis.
Main Results:
- DWORF-/- mice showed normal cardiac function and LVEF throughout aging compared to WT controls.
- R14-/- mice developed reduced LVEF by 18 months of age, but DWORF deletion did not accelerate this decline.
- Absence of DWORF did not increase cardiac remodeling, fibrosis markers, or fibrosis in R14-/- mice.
Conclusions:
- DWORF deletion does not accelerate or exacerbate PLN-R14del cardiomyopathy in mice.
- DWORF is dispensable for maintaining cardiac function during aging in mice.
- DWORF gene expression changes are unlikely to explain clinical variability in human PLN-R14del cardiomyopathy.
Abstract:
The phospholamban (PLN) pathogenic gene variant p.Arg14del causes cardiomyopathy, which is characterized by perinuclear PLN protein clustering and can lead to severe heart failure (HF). Elevated expression of dwarf open reading frame (DWORF), a protein counteracting the function of PLN in the sarcoplasmic reticulum (SR), can delay disease progression in a PLN-R14del mouse model. Here, we evaluated whether deletion of DWORF (DWORF) would have an opposite effect and accelerate age-dependent disease progression in wild-type (WT) mice and mice with a pathogenic PLN-R14del allele (R14). We show that DWORF mice maintained a normal left ventricular ejection fraction (LVEF) during aging and no difference with WT control mice could be observed up to 20 mo of age. R14 mice maintained a normal cardiac function until 12 mo of age, but at 18 mo of age, LVEF was significantly reduced as compared with WT mice. Absence of DWORF did neither accelerate the R14-induced reduction in LVEF nor enhance the increases in gene expression of markers related to cardiac remodeling and fibrosis and did not exacerbate cardiac fibrosis caused by the R14 mutation. Together, these results demonstrate that absence of DWORF does not accelerate or exacerbate PLN-R14del cardiomyopathy in mice harboring the pathogenic R14del allele. In addition, our data indicate that DWORF appears to be dispensable for cardiac function during aging.NEW & NOTEWORTHY Although DWORF overexpression significantly delayed heart failure development and strongly prolonged life span in PLN-R14del mice, the current study shows that deletion of DWORF does not accelerate or exacerbate PLN-R14del cardiomyopathy in mice harboring the pathogenic R14del allele. In addition, DWORF appears to be dispensable for cardiac function during aging. Changes in DWORF gene expression are therefore unlikely to contribute to the clinical heterogeneity observed in patients with PLN-R14del cardiomyopathy.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

